Author | Patti Barkey, COE, OCS

Articles

Pass-through provides vehicle to drive innovation

As more novel ophthalmic drugs and devices become available under the CMS “pass-through”designation, practices should be proactive in embracing these products.

New content coming soon, please check back later.